MIMS Education

Statin therapy and its role in managing ASCVD risk

Statin therapy and its role in managing ASCVD risk

A badge with ribbon in color black Point(s): 1 | An analog clock in color black 30 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 25 Nov 2022 


Atherosclerotic cardiovascular disease (ASCVD) has a major impact on public health, contributing to a significant number of deaths each year. This module focuses on the use of statin therapy and its role in reducing ASCVD risk and disease. Upon completion, participants in this module will gain insights into the following topics:

             Global and local burden of ASCVD

             Treatment guidelines and recommendations

             Efficacy and safety of statin therapy

             Clinical evidence of rosuvastatin (a high-intensity statin)

CPD Reviewer: 

Dr Foo Yoke Loong

Consultant Cardiologist and Physician

Sunway Medical Centre Velocity

Supported by AstraZeneca

Who should participate:

• Doctors


Please watch the video before attempting the assessment questions.

Terms & Conditions:

Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by: